To begin each module, results of interactive audience polling using networked iPads will be juxtaposed with the findings from a survey comprising case-based and related management questions completed by 25 clinical investigators prior to the meeting. Each faculty member will then deliver a presentation reviewing recently published research data and ongoing clinical trials related to the topics and questions addressed via the surveys. After each presentation, moderated panel discussion will take place to generate other relevant perspectives and dialogue.
MODULE 1: The Emergence of Targeted Therapy for Patients with Metastatic Colorectal Cancer (mCRC) and BRAF V600E Tumor Mutations; HER2 and Other Potential Biomarkers — Dr Hochster
MODULE 2: Lingering Questions in the Selection and Sequence of Therapy for Patients with mCRC — Dr Marshall
MODULE 3: Current and Emerging Role of Immune Checkpoint Inhibitors in the Management of mCRC — Dr Overman
MODULE 4: Optimal Management of Metastatic Gastric/Gastroesophageal Cancer — Dr Denlinger
MODULE 5: Contemporary Treatment Approaches for Patients with Pancreatic Cancer — Dr Philip
MODULE 6: PARP Inhibition in Pancreatic Cancer; Promising Investigational Strategies — Prof Van Cutsem
Target Audience
This activity is intended for medical oncologists, hematology-oncology fellows, surgeons and other healthcare providers involved in the treatment of gastrointestinal cancers.
Learning Objectives
At the conclusion of this activity, participants should be able to:
CME Credit Form
A CME credit form will be given to each participant at the conclusion of the activity.
Accreditation Statement
Research To Practice is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Credit Designation Statement
Research To Practice designates this live activity for a maximum of 2.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Disclosure Policy
Research To Practice (RTP) is committed to providing its participants with high-quality, unbiased and state-of-the-art education. We assess conflicts of interest with faculty, planners and managers of CME activities. Conflicts of interest are identified and resolved through a conflict of interest resolution process. In addition, all activity content is reviewed by both a member of the RTP scientific staff and an external, independent physician reviewer for fair balance, scientific objectivity of studies referenced and patient care recommendations. Financial disclosures will be provided in meeting course materials.
Supporters
This activity is supported by educational grants from Array BioPharma Inc, Bayer HealthCare Pharmaceuticals, Boston Biomedical Inc and Tolero Pharmaceuticals, Celgene Corporation, Ipsen Biopharmaceuticals Inc, Merck, Seattle Genetics, and Taiho Oncology Inc.
InterContinental San Francisco
888 Howard Street
San Francisco, CA 94103
Hotel Phone: (415) 616-6500
Meeting Room
Grand Ballroom (Third Floor)
Directions
The InterContinental San Francisco hotel is adjacent to the Moscone Center, where the 2020 Gastrointestinal Cancers Symposium is taking place.
Thank you for your interest in our CME program. At this time online preregistration is closed for this event. SEATS ARE STILL AVAILABLE FOR THIS SESSION. Our onsite registration desk will be open at 5:45 PM on Thursday, January 23rd. If you are interested in attending, please visit our registration desk outside the Grand Ballroom (third floor) of the InterContinental San Francisco hotel (888 Howard Street) near the Moscone Convention Center.
We will accept onsite registration on a first come, first served basis but with priority given to clinicians in practice. Please note, onsite registration does not guarantee participation in the session or meal service.
If you have any questions, please feel free to contact us via email at Meetings@ResearchToPractice.com or call (800) 233-6153.
NOTICE:
Registration for this event is independent of registration for the Gastrointestinal Cancers Symposium.